Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR038346-05
Application #
3158501
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Project Start
1987-05-01
Project End
1992-04-30
Budget Start
1991-05-01
Budget End
1992-04-30
Support Year
5
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Jee, W S; Ma, Y F (1997) The in vivo anabolic actions of prostaglandins in bone. Bone 21:297-304
Ma, Y F; Lin, B Y; Jee, W S et al. (1997) Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats. J Bone Miner Res 12:267-75
Ma, Y F; Li, X J; Jee, W S et al. (1995) Effects of prostaglandin E2 and F2 alpha on the skeleton of osteopenic ovariectomized rats. Bone 17:549-54
Ma, Y; Chen, Y Y; Jee, W S et al. (1995) Co-treatment of PGE2 and risedronate is better than PGE2 alone in the long-term treatment of ovariectomized-induced osteopenic rats. Bone 17:267S-272S
Chen, H K; Jee, W S; Ma, Y F et al. (1995) Intermittent treatment of prostaglandin E2 with risedronate is more anabolic than prostaglandin E2 alone in the proximal tibial metaphysis of ovariectomized rats. Bone 17:285S-289S
Yamamoto, N; Jee, W S; Ma, Y F (1995) Bone histomorphometric changes in the femoral neck of aging and ovariectomized rats. Anat Rec 243:175-85
Ijiri, K; Jee, W S; Ma, Y F et al. (1995) Remobilization partially restored the bone mass in a non-growing cancellous bone site following long term immobilization. Bone 17:213S-217S
Jee, W S; Lin, B Y; Ma, Y F et al. (1995) Extra cancellous bone induced by combined prostaglandin E2 and risedronate administration is maintained after their withdrawal in older female rats. J Bone Miner Res 10:963-70
Ma, Y; Jee, W S; Chen, Y et al. (1995) Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats. J Bone Miner Res 10:1726-34
Liang, H H; Ma, Y F; Jee, W S et al. (1995) Risedronate plus prostaglandin E2 is superior to prostaglandin E2 alone in maintaining the added bone after withdrawal in a non-growing bone site in ovariectomized rats. Bone 17:335S-339S

Showing the most recent 10 out of 56 publications